Back to Screener

Healthcare

Innovent Biologics, Inc.(IVBXF)

Live Price

Offline

$9.96

+0.00% today

1Y Change

-3.78%

Window

Jun 26, 2025 โ†’ Jun 23, 2026

Market Cap
$134.89B
Revenue Growth
+34.8%
EPS Growth
+909.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Innovent Biologics, Inc. (IVBXF) is a Healthcare stock with a market cap of $134.89B and listed on OTC. The stock last traded around $9.96 and down 3.8% across the available one-year price window (Jun 26, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +34.8%, EPS growth of +909.0%, a dividend yield of 0.0%. What stands out right now is revenue +34.8%, EPS +909.0%, free cash flow 0.0% with operating margin 11.3% and ROIC 4.7%. Valuation already assumes a fairly strong business story at P/E 87.5 and price/sales 10.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IVBXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IVBXF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IVBXF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IVBXF Max Drawdown

-33.87%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IVBXF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsAug 26, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 26, 26
TBD
โ€”
Est 0.08
โ€”
โ€”
Est 1195422.0B
โ€”
Aug 26
โ€”
Mar 26, 26
โœ—
-0.00
Est 0.02
-108.3%
1013300.0B
Est 985896.6B
+2.8%
Mar 26
โ€”
Aug 27, 25
โœ“
0.07
Est 0.03
+173.3%
830159.0B
Est 790349.2B
+5.0%
Aug 27
โ€”
Mar 26, 25
โœ“
0.03
Est -0.03
+179.4%
749116.0B
Est 637093.4B
+17.6%
Mar 26
โ€”
Aug 28, 24
โœ“
-0.03
Est -0.03
+3.2%
543874.8B
Est 521163.0B
+4.4%
Aug 28
โ€”
Mar 20, 24
โœ—
-0.08
Est -0.07
-12.5%
494815.7B
Est 481538.5B
+2.8%
Mar 20
โ€”
Jun 30, 23
โœ“
-0.01
Est -0.10
+87.4%
372879.0B
Est 359624.6B
+3.7%
Jun 30
โ€”
Dec 31, 22
โœ“
-0.12
Est -0.17
+30.7%
338381.3B
Est 316047.6B
+7.1%
Dec 31
โ€”
Jun 30, 22
โœ“
-0.10
Est -0.15
+36.4%
334163.1B
Est 313792.7B
+6.5%
Jun 30
โ€”
Dec 31, 21
โœ—
-0.19
Est -0.14
-29.5%
365553.2B
Est 320819.9B
+13.9%
Dec 31
โ€”
Jun 30, 21
โœ—
-0.11
Est -0.04
-188.1%
300249.6B
Est 308313.5B
-2.6%
Jun 30
โ€”
Dec 31, 20
โœ—
-0.04
Est 0.06
-172.0%
438064.1B
Est 432488.1B
+1.3%
Dec 31
โ€”
Jun 30, 20
โœ—
-0.07
Est -0.04
-53.7%
139391.5B
Est 179163.7B
-22.2%
Jun 30
โ€”
Dec 31, 19
-0.12
Est โ€”
โ€”
101845.3B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 19
-0.09
Est โ€”
โ€”
50279.6B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 18
-1.70
Est โ€”
โ€”
770.0B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 18
0.02
Est โ€”
โ€”
669.9B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 17
-0.53
Est โ€”
โ€”
9760.9B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 17
-0.35
Est โ€”
โ€”
1568.7B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 16
-0.03
Est โ€”
โ€”
2311.2B
Est โ€”
โ€”
Dec 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener